Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 3
1965 2
1967 2
1969 1
1970 1
1972 5
1973 1
1975 2
1976 2
1977 4
1978 2
1980 2
1981 7
1982 5
1983 5
1984 4
1985 7
1986 8
1987 8
1988 4
1989 5
1990 6
1991 10
1992 13
1993 16
1994 32
1995 17
1996 14
1997 25
1998 29
1999 28
2000 15
2001 26
2002 24
2003 18
2004 28
2005 29
2006 25
2007 28
2008 33
2009 38
2010 29
2011 39
2012 37
2013 37
2014 39
2015 44
2016 46
2017 52
2018 55
2019 59
2020 58
2021 73
2022 69
2023 79
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

1,161 results

Results by year

Filters applied: . Clear all
Page 1
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Among authors: morales c. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer's disease.
León R, Gutiérrez DA, Pinto C, Morales C, de la Fuente C, Riquelme C, Cortés BI, González-Martin A, Chamorro D, Espinosa N, Fuentealba P, Cancino GI, Zanlungo S, Dulcey AE, Marugan JJ, Álvarez Rojas A. León R, et al. Among authors: morales c. Front Aging Neurosci. 2023 Jun 5;15:1180987. doi: 10.3389/fnagi.2023.1180987. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37358955 Free PMC article.
Adeno-associated virus type 2 in US children with acute severe hepatitis.
Servellita V, Sotomayor Gonzalez A, Lamson DM, Foresythe A, Huh HJ, Bazinet AL, Bergman NH, Bull RL, Garcia KY, Goodrich JS, Lovett SP, Parker K, Radune D, Hatada A, Pan CY, Rizzo K, Bertumen JB, Morales C, Oluniyi PE, Nguyen J, Tan J, Stryke D, Jaber R, Leslie MT, Lyons Z, Hedman HD, Parashar U, Sullivan M, Wroblewski K, Oberste MS, Tate JE, Baker JM, Sugerman D, Potts C, Lu X, Chhabra P; Pediatric Hepatitis of Unknown Etiology Working Group; Ingram LA, Shiau H, Britt W, Gutierrez Sanchez LH, Ciric C, Rostad CA, Vinjé J, Kirking HL, Wadford DA, Raborn RT, St George K, Chiu CY. Servellita V, et al. Among authors: morales c. Nature. 2023 May;617(7961):574-580. doi: 10.1038/s41586-023-05949-1. Epub 2023 Mar 30. Nature. 2023. PMID: 36996871 Free PMC article.
Increased incidence of rheumatoid arthritis after COVID-19.
Marín JS, Mazenett-Granados EA, Salazar-Uribe JC, Sarmiento M, Suárez JF, Rojas M, Munera M, Pérez R, Morales C, Dominguez JI, Anaya JM. Marín JS, et al. Among authors: morales c. Autoimmun Rev. 2023 Oct;22(10):103409. doi: 10.1016/j.autrev.2023.103409. Epub 2023 Aug 18. Autoimmun Rev. 2023. PMID: 37597602 Review.
Observation of Z_{c}(3900)^{0} in e^{+}e^{-}→π^{0}π^{0}J/ψ.
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, Amoroso A, An FF, An Q, Bai JZ, Ferroli RB, Ban Y, Bennett DW, Bennett JV, Bertani M, Bettoni D, Bian JM, Bianchi F, Boger E, Boyko I, Briere RA, Cai H, Cai X, Cakir O, Calcaterra A, Cao GF, Cetin SA, Chang JF, Chelkov G, Chen G, Chen HS, Chen HY, Chen JC, Chen ML, Chen SJ, Chen X, Chen XR, Chen YB, Cheng HP, Chu XK, Cibinetto G, Dai HL, Dai JP, Dbeyssi A, Dedovich D, Deng ZY, Denig A, Denysenko I, Destefanis M, De Mori F, Ding Y, Dong C, Dong J, Dong LY, Dong MY, Du SX, Duan PF, Eren EE, Fan JZ, Fang J, Fang SS, Fang X, Fang Y, Fava L, Feldbauer F, Felici G, Feng CQ, Fioravanti E, Fritsch M, Fu CD, Gao Q, Gao XY, Gao Y, Gao Z, Garzia I, Geng C, Goetzen K, Gong WX, Gradl W, Greco M, Gu MH, Gu YT, Guan YH, Guo AQ, Guo LB, Guo Y, Guo YP, Haddadi Z, Hafner A, Han S, Han YL, Hao XQ, Harris FA, He KL, He ZY, Held T, Heng YK, Hou ZL, Hu C, Hu HM, Hu JF, Hu T, Hu Y, Huang GM, Huang GS, Huang HP, Huang JS, Huang XT, Huang Y, Hussain T, Ji Q, Ji QP, Ji XB, Ji XL, Jiang LL, Jiang LW, Jiang XS, Jiang XY, Jiao JB, Jiao Z, Jin DP, Jin S, Johansson T, Julin A, Kalantar-Nayestanaki N, Kang XL, Kang XS, Kavatsyuk M, Ke BC, Kiese P,… See abstract for full author list ➔ Ablikim M, et al. Among authors: morales cm. Phys Rev Lett. 2015 Sep 11;115(11):112003. doi: 10.1103/PhysRevLett.115.112003. Epub 2015 Sep 11. Phys Rev Lett. 2015. PMID: 26406823 Free article.
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Among authors: morales c. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. CRASH-2 collaborators, et al. Among authors: morales c. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. doi: 10.1016/S0140-6736(11)60278-X. Lancet. 2011. PMID: 21439633 Clinical Trial.
N-acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function.
Da Silva A, Dort J, Orfi Z, Pan X, Huang S, Kho I, Heckel E, Muscarnera G, van Vliet PP, Sturiale L, Messina A, Romeo DA, van Karnebeek CDM, Wen XY, Hinek A, Molina T, Andelfinger G, Ellezam B, Yamanaka Y, Olivos HJ, Morales CR, Joyal JS, Lefeber DJ, Garozzo D, Dumont NA, Pshezhetsky AV. Da Silva A, et al. Among authors: morales cr. Sci Adv. 2023 Jun 30;9(26):eade6308. doi: 10.1126/sciadv.ade6308. Epub 2023 Jun 30. Sci Adv. 2023. PMID: 37390204 Free PMC article.
Epicardial Adipose Tissue in Cardiovascular Disease.
Berg G, Miksztowicz V, Morales C, Barchuk M. Berg G, et al. Among authors: morales c. Adv Exp Med Biol. 2019;1127:131-143. doi: 10.1007/978-3-030-11488-6_9. Adv Exp Med Biol. 2019. PMID: 31140176 Review.
1,161 results